United Laboratories, Inc., a pharmaceutical and healthcare company, develops, manufactures, and markets prescription, consumer healthcare, and personal care products in various therapeutic categories. The company offers various tablets, capsules, drops, syrups, injections, and powders. It develops and markets a range of ethical and consumer products in various therapeutic segments, including anti-allergy, anti-asthma-copd, anti-fibrinolytics, anti-infectives, anti-TB, cardiovascular, central nervous system, cosmetics, cough-cold, dermatologicals, dietetics, endometabolics, eye-ear, gastrointestinal, genito-urinary-nephro, hospital solutions, medical device, OB-gyne, oncology, oral care, soma...
66 United Street
Mandaluyong City, 1550
Founded in 1945
United Laboratories and Debiopharm International Launch Pamorelin in the Philippines
Dec 10 15
United Laboratories (Philippines) and Debiopharm International (Switzerland) have entered into an distribution and commercialisation agreement for Pamorelin (triptorelin pamoate) in the Philippines, for the treatment of locally advanced and metastatic hormone-dependent prostate cancer; as an adjuvant to radiotherapy in high-risk localised and locally advanced prostate cancer and endometriosis.
Nipro Pharma Enters Partnership with United Laboratories to Target Asian Market
Oct 9 14
Nipro Pharma has entered a collaboration with United Laboratories (Philippines) to market the Japanese company's pharmaceutical treatments in the Asian market. Under the agreement, United Laboratories will first market Nipro's products in the Philippines. The partnership is expected to be positive for Nipro and United Laboratories. Nipro will be able to leverage the extensive network of United Laboratories, which is the Philippines' larger pharmaceutical firm. Both companies are aiming to tap rapidly growing demand for affordable and safe generics in the Philippines, which has seen other firms pile into the increasingly competitive space.